BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2716944)

  • 1. [Review: arterial hypertension and advanced age].
    Loew F; Jacot des Combes B; Gauthey L; Herrmann F
    Nephrologie; 1989; 10(1):5-10. PubMed ID: 2716944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and hypertension.
    Fukutomi M; Kario K
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1531-9. PubMed ID: 21090928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment of hypertension in the elderly: a Korean perspective.
    Kim KI; Cho YS; Choi DJ; Kim CH
    Geriatr Gerontol Int; 2008 Mar; 8(1):5-11. PubMed ID: 18713183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of hypertension in the elderly.
    Alebiosu CO
    Niger Postgrad Med J; 2001 Sep; 8(3):150-4. PubMed ID: 11721219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive agents in elderly patients].
    Belmin J
    Rev Prat; 1990 May; 40(15):1379-84. PubMed ID: 2356428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approach to hypertension in the elderly.
    Sowers JR; Khoury S; Imam K; Byyny R
    Prim Care; 1991 Sep; 18(3):593-605. PubMed ID: 1946789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden.
    Amery A; Hansson L; Andrén L; Gudbrandsson T; Sivertsson R; Svensson A
    Acta Med Scand; 1981; 210(3):221-9. PubMed ID: 7293840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinating drug use and exercise in elderly hypertensives.
    Lowenthal DT; Wheat M; Kuffler LA
    Geriatrics; 1988 Jun; 43(6):69-70, 72-4, 76-80. PubMed ID: 3366385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baroreflexes and cardiovascular regulation in hypertension.
    Head GA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in the elderly: benefits of treatment.
    Chalmers J
    Blood Press Suppl; 1995; 3():6-10. PubMed ID: 8535544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal and cardiovascular protection associated to antihypertensive treatment in the elderly].
    Luño J; García de Vinuesa S
    Nefrologia; 2002; 22 Suppl 1():30-5. PubMed ID: 11987668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension: questions of prevalence, diagnosis, and management. Medical Technology and Practice Patterns Institute.
    J Clin Hypertens; 1987 Dec; 3(4):757-67. PubMed ID: 3453401
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.